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Abstract
Background: Although the most frequent extra-pulmonary manifestations of respiratory syncytial virus (RSV)
infection involve the cardiovascular system, no data regarding heart function in infants with bronchiolitis associated
with RSV infection have yet been systematically collected. The aim of this study was to verify the real frequency of
heart involvement in patients with bronchiolitis associated with RSV infection, and whether infants with mild or
moderate disease also risk heart malfunction.
Methods: A total of 69 otherwise healthy infants aged 1-12 months with bronchiolitis hospitalised in standard
wards were enrolled. Pernasal flocked swabs were performed to collect specimens for the detection of RSV by real-
time polymerase chain reaction, and a blood sample was drawn to assess troponin I concentrations. On the day of
admission, all of the infants underwent 24-hour Holter ECG monitoring and a complete heart evaluation with
echocardiography. Patients were re-evaluated by investigators blinded to the etiological and cardiac findings four
weeks after enrolment.
Results: Regardless of their clinical presentation, sinoatrial blocks were identified in 26/34 RSV-positive patients
(76.5%) and 1/35 RSV-negative patients (2.9%) (p < 0.0001). The blocks recurred more than three times over
24 hours in 25/26 RSV-positive patients (96.2%) and none of the RSV-negative infants. Mean and maximum heart
rates were significantly higher in the RSV-positive infants (p < 0.05), as was low-frequency power and the low and
high-frequency power ratio (p < 0.05). The blocks were significantly more frequent in the children with an RSV
load of ≥100,000 copies/mL than in those with a lower viral load (p < 0.0001). Holter ECG after 28 ± 3 days
showed the complete regression of the heart abnormalities.
Conclusions: RSV seems associated with sinoatrial blocks and transient rhythm alterations even when the related
respiratory problems are mild or moderate. Further studies are needed to clarify the mechanisms of these rhythm
problems and whether they remain asymptomatic and transient even in presence of severe respiratory
involvement or chronic underlying disease.
Background
The most frequent extra-pulmonary manifestations of
respiratory syncytial virus (RSV) infection involve the
cardiovascular system [1], and include cardiovascolar fail-
ure with hypotension and inotrope requirement, asso-
ciated with myocardial damage, cardiac arrhythmias and
pericardial tamponade, particularly in patients admitted
to pediatric intensive care units (PICUs) [2-9]. However,
the reasons leading to heart involvement during RSV
infection are not fully known. As severe bronchiolitis can
be associated with pulmonary hypertension [10], it has
been thought that the disease itself may lead to right ven-
tricular decompensation with myocardial damage, high
cardiac troponin levels and systolic hypotension [11].
Furthermore, it has been demonstrated in other lung
diseases, such as bacterial pneumonia, that severe lung
involvement can be accompanied by a significant increase
in troponin I and T concentrations [12,13] and it is well
known that right ventricular strain may precipitate
arrhythmias [14]. However, the detection of RSV in myo-
cardial tissue [15,16] and the occurrence of significant
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pericardial effusion in children with severe RSV bronch-
iolitis [17-19] suggest that the virus itself may play a
direct role in causing heart disease.
As clinically relevant heart problems are usually found
in infants whose bronchiolitis is severe enough to require
mechanical ventilation [3,6], it is recommended that
heart rate and blood pressure should be systematically
and carefully monitored in those admitted to PICUs [19],
but not in those admitted to semi-intensive or normal
pediatric wards. However, no data regarding heart func-
tion in infants with bronchiolitis associated with RSV
infection have yet been systematically collected although
they could throw new light on the pathogenesis of heart
involvement during RSV infection and further define the
best approach to bronchiolitis.
The aim of this study was to verify the real frequency
of heart involvement in patients with bronchiolitis asso-
ciated with RSV infection, and whether infants with
mild or moderate disease also risk heart malfunction.
Methods
Study design
This prospective study was carried out at the Depart-
ment of Maternal and Pediatric Sciences of the Univer-
sity of Milan, Italy, during the winter seasons 2007-2008
and 2008-2009. The protocol was approved by the local
Ethics Committee, and written informed consent to
study participation was obtained from the patients’ par-
ents or legal guardians.
Study population
The study involved otherwise healthy infants aged 1-12
months who were admitted to hospital because of
bronchiolitis during the study period. The exclusion cri-
teria were the presence of a chronic disease increasing
the risk of complications of respiratory infection, includ-
ing chronic disorders of the pulmonary or cardiovascu-
lar system, chronic metabolic disease, neoplasms, kidney
or liver dysfunction, hemoglobinopathies, immunosup-
pression, and genetic or neurological disorders. There
was no refusal to participate.
Upon admission, the infants’ demographic characteris-
tics and medical history were systematically recorded
using standardised written questionnaires and, after a
complete physical examination, the subjects with a diag-
nosis of bronchiolitis based on well-established criteria
[20] were enrolled. The severity of the disease was
defined on the basis of a global evaluation of the signs
and symptoms. In particular, on the basis of previously
published criteria [20], respiratory illness was considered
severe in the presence of all of ≤ 92% pulse oximetry, a
respiratory rate of ≥60 breaths/min, marked accessory
muscle use, nasal flare or grunting, a heart rate of > 180
beats/min, an inability to feed and a toxic appearance.
All of the patients underwent chest radiography, and
pneumonia was defined on the basis of the presence of
a reticular-nodular infiltrate, segmental or lobar consoli-
dation, or bilateral consolidation [21].
Upon enrolment, Virocult (Medical Wire and Equip-
ment, Corsham, UK) nasopharyngeal swabs were used to
collect specimens for the detection of RSV, and a blood
sample was drawn to assess troponin I concentrations.
On the basis of our previous experience in children with
bronchiolitis in which we showed that RSV was the main
cause of acute episodes in hospitalized children [22], in
this study only RSV was searched on nasopharyngeal
secretions. Finally, on the day of admission, all of the
infants underwent 24-hour Holter ECG monitoring and a
complete heart evaluation with echocardiography. It was
decided to estimate pulmonary pressure as well as signs
of pulmonary hypertension only in presence of patholo-
gic findings at echocardiography.
During their hospital stay, the infants’ clinical signs and
symptoms were monitored daily. They were treated with
oxygen when saturation was ≤ 95%, and received inhala-
tory bronchodilators, steroids, antibiotics, intravenous
fluids and chest physiotherapy on the basis of the judge-
ment of the attending pediatrician. They were discharged
when they were able to maintain > 95% oxymetry without
oxygen, but their parents were asked to bring them
immediately to the study centre if there were any recur-
rent or worsening signs and symptoms.
The medical history, general physical condition and
clinical symptoms of each patient were re-evaluated by
investigators blinded to the etiological and cardiac find-
ings four weeks after enrolment. During this follow-up
visit, the patients’ history of respiratory tract infections
was carefully assessed and 24-hour Holter ECG moni-
toring 24 hours was repeated.
Identification of RSV virus
The Virocult nasopharyngeal swabs were tested by means
of previously described real-time polymerase chain reac-
tion (PCR) for RSV types A and B [21-24], with total
nucleic acids being routinely isolated at the MagnaPureLC
Isolation Station (Roche Applied Science, Penzberg,
Germany). A universal internal control virus (phocine
distemper virus, PDV) was used to monitor the whole
process from nucleic acid isolation to real-time detection.
The in-house real-time PCRs for RSV and PDV were
designed using primer express software (Applied Bio-
system, Nieuwerkerk a/d Ijssel, The Netherlands).
RNA was amplified in a single tube, two-step reaction
using Taqman reverse transcriptase and PCR core
reagent kits (Applied Biosystems, Foster City, CA, USA)
and an ABI 7700 or ABI 7500 sequence detection system
(Applied Biosystems). A cultured positive control virus
was used for each assay. On the basis of proficiency
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testing data, the sensitivity of each assay was estimated to
be less than 500 copies ⁄ mL.
Evaluation of myocardial damage
To evaluate myocardial damage, serum troponin I levels
were measured using the Abbott AxSYM system
(Abbott Laboratories, Mississauga, Ontario, Canada) at
the time of hospital admission, and were considered
indicative of myocardial damage when they were > 1.2
μg/L. The measurements had a coefficient of variation
of 10%, and the lower detection limit was 0.3 μg/L.
Holter ECG monitoring
Three-channel Holter monitors (ElaMedical Spider View
3 channel recorders, Le Plessis-Robinson, France) were
positioned immediately after hospital admission, and 24-
hour recordings were obtained. After the skin had been
prepared, the electrodes were placed to record leads II,
V1 and V5; a 1 mV calibration signal was also recorded.
The built-in clock started after the electrodes had been
attached.
A commercial Holter analysis software (SyneScope,
Elamedical, Sorin Group, Le Plessis-Robinson, France) was
used to analyse rhythm and heart rate variability (HRV,
time-, frequency- and geometric-domain indices) from the
Holter tapes. QRS was detected using a level detector, but
was manually over-read by a physician. All of the tapes
were edited in order to assure the accuracy of the QRS
classification. Ectopic beats, noisy data, and artifacts were
manually identified and excluded from the HRV analysis.
Non-stationarities were avoided by means of trigger
adjustment. Average hourly heart rates were determined
from the computerised Holter scanner, and maximum,
minimum, and mean 24-hour heart rates (with standard
deviations, SDs) were calculated for each subject.
The time-domain parameters measured from the Holter
tapes were: 1) the average of all normal-to-normal beats
(mean NN interval) (mean heart rate); 2) the SD of all NN
intervals (SDNN); 3) the SD of the average of NN intervals
in all 5-minute segments of the 24-hour recording
(SDANN); 4) the mean of the standard deviation in all
5-minute segments of the 24-hour recording (ASDNN); 5)
the square root of the mean of the squares of the differ-
ences between adjacent NN intervals (rMSSD); and 6) the
percentage of > 50 msec differences between adjacent NN
intervals. Frequency-domain heart rate variability was also
determined, including low-frequency power (LF, total NN
interval spectral power between 0.04 and 0.15 Hz), high-
frequency power (HF, total interval spectral power
between 0.15 and 0.4 Hz), and the LF/HF ratio [25].
Echocardiographic studies
The echocardiographic studies were made using a real-
time ultrasound imaging system system (Acuson Sequoia
512) equipped with 3-, 5-, 7 and 10A, MHz transducers.
The echocardiographic measurements were made using
standard techniques [26].
M-mode measurements were made in accordance with
the recommendations of the Cornmittee of M-Mode
Standardization of the American Society of Echocardio-
graphy [27], and were used to determine right ventricu-
lar internal dimension in diastole (RVID) and left
ventricular internal dimensions in diastole (LVID) and
systole (LVIS). Left ventricular function was assessed by
calculating the percentage fractional shortening of the
internal dimension and ejection fraction using standard
formulas. Left ventricular mass was also calculated.
The flow velocities across the mitral, tricuspid, aortic
and pulmonary valves were recorded from standard
pericordial and subcostal positions using pulsed-wave
and continuous-wave Doppler transducers.
Statistical analysis
Continuous variables are given as mean values ± SD,
and categorical variables as numbers and percentages.
For the comparison between groups (i.e., RSV-positive
vs RSV-negative), the continuous data were analysed
using a two-sided Student’s test if they were normally
distributed (on the basis of the Shapiro-Wilk statistic)
or a two-sided Wilcoxon rank-sum test if they were not.
For the comparison within group (i.e., admission vs 28 ±
3 days after admission in the RSV-positive and RSV-
negative groups, separately), the continuous data were
analysed using a paired two-sided Student’s test or
signed-rank test, as appropriate. Categorical data were
analysed using contingency table analysis and the chi-
square or Fisher’s exact test, as appropriate.
Results
Sixty-nine children with bronchiolitis were enrolled: 34
(49.3%) RSV-positive and 35 (50.7%) RSV-negative.
Table 1 shows that there were no differences in gender,
age at enrolment, type of delivery, gestational age at
birth, birth weight, respiratory problems at birth,
respiratory infections or antibiotic courses in the pre-
vious three months between the two groups.
Table 2 shows the data regarding clinical presentation.
Bronchiolitis was mild or moderate in most cases: only
three RSV-positive (8.8%) and three RSV-negative
patients (8.6%) had severe disease. Disease signs and
symptoms, laboratory parameters, radiographic findings,
the need for rehydration and oxygen, and the use of
antibiotics, steroids, inhalatory bronchodilators, drugs
interacting with cardiovascular system and chest phy-
siotherapy were similar in the two groups. None of the
patients required PICU admission. None was treated
with oral or intravenous bronchodilators. Clinical and
echocardiography evaluations showed that the
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cardiovascular system was always normal, as were car-
diac troponin I concentrations.
Table 3 summarises the Holter ECG monitoring data.
Sinoatrial blocks occurred in 26 RSV-positive patients
(76.5%) and only one RSV-negative patient (2.9%) (p <
0.0001). Twenty-five of the 26 RSV-positive patients
(96.2%), but not the RSV-negative patient, experienced
more than three sinoatrial blocks during the 24 hours,
Table 1 Demographic characteristics of the study population
Characteristic RSV- positive
n = 34
RSV-negative
n = 35
P value
Males, No. (%) 18 (52.9) 18 (51.4) 0.90
Mean age at enrolment, days ± SD 142.41 ± 104.8 114.69 ± 108.4 0.22
Type of delivery
Eutocic, No. (%) 20 (58.8) 20 (57.1) 0.89
Caesarean, No. (%) 14 (41.2) 15 (42.9)
Gestational age at birth, mean weeks ± SD 37.06 ± 3.63 36.66 ± 3.80 0.66
Birth weight, mean ± SD 2.95 ± 0.86 2.77 ± 0.75 0.34
Respiratory problems at birth, No. (%) 7 (20.6) 8 (22.9) 0.82
Ventilatory support at birth, No. (%) 5 (14.7) 8 (22.9) 0.39
Patients with respiratory infections in previous 3 months, No. (%) 12 (35.3) 8 (22.9) 0.25
Patients treated with antibiotic courses in previous 3 months, No. (%) 6 (17.7) 5 (14.3) 0.70
SD: standard deviation. P-value for comparison between groups, using chi-square or Fisher’s exact test, as appropriate, for categorigal data and Student’s test or
Wilcoxon rank-sum test, as appropriate, for continuous variables.
Table 2 Clinical presentation at enrolment
Characteristic RSV- positive
n = 34
RSV-negative
n = 35
P value
Severe bronchiolitis, No. (%) 3 (8.8) 3 (8.6) 1.00
Acute onset, No. (%) 6 (17.7) 11 (31.4) 0.18
Rectal temperature ≥38°C, No. (%) 7 (20.6) 6 (17.1) 0.29
Mean temperature ± SD, °C 37.44 ± 0.74 37.02 ± 0.74 0.19
Mean breath frequency ± SD 54.79 ± 14.06 53.73 ± 12.34 0.78
Dyspnea, No. (%) 21 (61.8) 16 (45.7) 0.18
Wheezing, No. (%) 17 (50.0) 16 (45.7) 0.72
Rales, No. (%) 28 (82.3) 29 (82.9) 0.96
Difficulties in feeding, No. (%) 18 (52.9) 12 (34.3) 0.12
Normal clinical heart assessment, No. (%) 34 (100.0) 35 (100.0) 1.00
Normal echocardiographic parameters, No. (%) 34 (100.0) 35 (100.0) 1.00
Mean cTnI ± SD, IU/L 0.009 ± 0.02 0.013 ± 0.02 0.51
Mean CPK ± SD, IU/L 99.27 ± 69.45 79.88 ± 47.32 0.24
Mean LDH ± SD, IU/L 701.96 ± 190.74 597.95 ± 154.17 0.06
Mean SGOT ± SD, IU/L 38.83 ± 10.91 39.57 ± 19.93 0.86
Mean SGPT ± SD, IU/L 23.93 ± 10.98 28.00 ± 14.30 0.22
Pneumonia at X-ray, No. (%) 22 (64.7) 17 (48.6) 0.18
Need for intravenous infusion, No. (%) 15 (44.1) 13 (37.1) 0.56
Need for oxygen therapy, No. (%) 18 (52.9) 21 (60.0) 0.55
Treated with antibiotics, No. (%) 24 (70.6) 21 (60.0) 0.36
Treated with inhalatory bronchodilator, No. (%) 34 (100.0) 35 (100.0) 1.00
Treated with steroids
Oral steroids, No. (%) 6 (17.6) 5 (14.3) 0.75
Intravenous steroids, No. (%) 2 (5.9) 2 (5.7) 1.00
Treated with drugs interacting with cardiovascular system, No. (%) 0 (0.0) 0 (0.0) -
Chest physiotherapy, No. (%) 1 (2.9) 2 (5.7) 0.98
SD: standard deviation; cTnI: cardiac troponin I; CPK: creatine phosphokinase; LDH: lactate dehydrogenase; SGOT: serum glutamyl oxaloacetic transaminase; SGPT:
serum glutamic pyruvic transaminase. P-value for comparison between groups, using chi-square or Fisher’s exact test, as appropriate, for categorigal data and
Student’s test or Wilcoxon rank-sum test, as appropriate, for continuous variables.
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with a maximum of 18 times in one patient. The blocks
lasted longer than one second in all cases, and more
than two seconds in five (14.7%) (p < 0.05 vs RSV-nega-
tive patients). Mean and maximum heart rate were sig-
nificantly higher in the RSV-positive infants (p < 0.05).
Among the HRV time-domain parameters, the preva-
lence of LF periods was significantly higher in the RSV-
positive infants (p < 0.05) as was the LF/HF ratio (p <
0.05). Twenty-four hour Holter ECG monitoring 28 ± 3
days later demonstrated the complete regression of the
heart abnormalities in all of the RSV-positive infants: no
block was recorded and their HRV parameters were
similar to those recorded in the RSV-negative patients
during the acute phase of the disease and during the
convalescent period.
Table 4 shows the associations between sinoatrial
block and the other variables in the infants with RSV
infection. The only variable that was independently
associated with the occurrence of sinoatrial block was
RSV viral load: blocks were significantly more frequent
in the infants with a viral load of ≥100,000 copies/mL
than in those with a lower viral load (p < 0.0001). The
association remains significant even after excluding
patients with severe disease. There was no association
between sinoatrial block and gestational age, birth
weight, neonatal problems, or the presentation or sever-
ity of bronchiolitis.
Discussion
The results of this study indicate that bronchiolitis dur-
ing the course of RSV infection is frequently associated
with sinoatrial blocks, an increase in absolute heart rate,
and an increase in the LF component of HRV. All of
these findings seem to be specific of RSV infection
because they have not been demonstrated in children
with bronchiolitis caused by a different infectious agent.
Our data confirm and extend what has been previously
reported by other authors who have found that RSV
infection can be associated with cardiac rhythm altera-
tions [8,9,28].
Sinoatrial blocks are rare in pediatrics but, when
symptomatic, have been described in otherwise healthy
children and patients with heart malformations or myo-
carditis [29]. To the best of our knowledge, this is the
first report that associates sinoatrial blocks and RSV
bronchiolitis. In our study population, the sinoatrial
blocks were always asymptomatic and disappeared with
recovery from the respiratory disease, thus suggesting
that they are reversible. Furthermore, the significantly
increased mean heart rates and the high incidence of
the LF components of HRV (usually considered a possi-
ble marker of cardiac damage) [25,26], were only
observed during the acute phase of RSV infection.
Moreover, none of the children showed any clinical sign
or symptom resembling those described in subjects with
Table 3 Heart rate variability in infants with bronchiolitis, by etiology
Variable Admission 28 ± 3 days after admission
RSV-positive
(n = 34)
RSV-negative
(n = 35)
RSV-positive
(n = 34)
RSV-negative
(n = 35)
Sinoatrial block, No. (%) 26 (76.5)°^ 1 (2.9) 0 (0.0) 0 (0.0)
Sinoatrial block 1-2 sec., No. (%) 21 (61.8)°^ 1 (2.9) 0 (0.0) 0 (0.0)
Sinoatrial block > 2 sec., No. (%) 5 (14.7)*” 0 (0.0) 0 (0.0) 0 (0.0)
More than 3 sinoatrial blocks, No. (%) 25 (96.2)°^ 0 (0.0) 0 (0.0) 0 (0.0)
Mean heart rate, bpm ± SD 139.23 ± 15.7*” 116.65 ± 15.9 119.37 ± 19.6 112.06 ± 10.1
Maximum heart rate, mean bpm ± SD 204.29 ± 20.6*” 173.30 ± 28.8 179.49 ± 21.8 170.10 ± 21.3
Minimum heart rate, mean bpm ± SD 49.62 ± 17.1 45.61 ± 26.10 49.31 ± 19.45 48.44 ± 20.14
SDNN (ms), mean ± SD 58.34 ± 26.37 54.61 ± 24.11 56.46 ± 22.21 55.39 ± 22.68
SDANN (ms), mean ± SD 49.61 ± 28.75 45.57 ± 25.70 47.66 ± 25.55 46.91 ± 26.96
ASDNN (ms), mean ± SD 37.11 ± 17.20 33.33 ± 13.70 35.64 ± 18.52 34.39 ± 16.31
rMSSD (ms), mean ± SD 20.31 ± 19.55 19.30 ± 16.99 19.25 ± 19.43 19.77 ± 19.03
PNN50, mean % ± SD 4.21 ± 7.2 2.93 ± 4.5 3.33 ± 5.3 3.22 ± 4.9
LF (ms2), mean ± SD 636.13 ± 306.7*” 369.48 ± 276.7 373.49 ± 269.73 369.55 ± 288.76
LF (nu), mean ± SD 33.93 ± 6.8*” 24.91 ± 5.6 25.01 ± 5.9 24.99 ± 6.1
HF (ms2), mean ± SD 271.06 ± 573.5 106.09 ± 152.5 143.9 ± 155.5 176.73 ± 169.6
HF (nu), mean ± SD 7.10 ± 7.6 6.76 ± 2.8 6.76 ± 4.5 6.85 ± 4.9
LF/HF ratio, mean ± SD 4.78 ± 1.60*” 3.68 ± 1.48 3.69 ± 1.40 3.64 ± 1.55
SD: standard deviation; bpm: beats per minute; SDNN: standard deviation of all NN intervals; SDANN: standard deviation of the average of NN intervals in all
5-minute segments of the 24-h recording; ASDNN: mean of the standard deviation in all 5-minute segments of the 24-h recording; rMSSD: square root of the
mean of the squares of the differences between adjacent NN intervals; pNN50: percentage of differences between adjacent NN intervals of > 50 msec; LF: low-
frequency power; HF: high-frequency power; nu: normalised units.
°p < 0.0001 and *p < 0.05 for the comparison between groups (i.e., RSV-positive vs RSV-negative upon admission); ^p < 0.0001 and “p < 0.05 for the comparison
within group (i.e., admission vs 28 ± 3 days after admission in the RSV-positive group); no other significant difference between or within-group.
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symptomatic sinoatrial block, any echocardiographic
alteration or any increase in troponin I concentrations.
All of these findings support the hypothesis that RSV
can specifically alter the electrical conduction system,
but that these alterations are benign and transient. Con-
sidering that current arrhythmia guidelines do not
recommend any kind of intervention in transient sinoa-
trial block [30], on the basis of our findings we do not
recommend routine cardiac monitoring of infants with
bronchiolitis in general wards. However, our findings
highlight the need of further studies on the impact of
sinoatrial blocks in patients with chronic underlying dis-
ease at risk of complications during RSV infection.
One limitation of this study is that the population is
too small to allow any definite conclusions to be drawn
and so further studies of larger series are needed. It
seems to be particularly important to study more severe
cases in order to verify whether more significant lung
involvement can precipitate arrhythmias and cause more
serious clinical problems. It is interesting that in our
population all the three cases of severe bronchiolitis
showed a sinoatrial block. The very low number of sub-
jects with severe infection could have limited the statis-
tical power to detect between group differences
according to disease severity. Another limitation is the
fact that only RSV has been searched in respiratory
Table 4 Associations between sinoatrial block and different variables in infants with bronchiolitis and RSV infection
Variable Patients with sinoatrial
block (n = 26)
Patients without
sinoatrial block (n = 8)
P
RSV viral load
< 100.000 cp/mL 4 (15.4) 8 (100.0) < 0.0001
≥100.000 cp/mL 22 (84.6) 0 (0.0)
Gestational age
≥37 weeks 10 (38.5) 4 (50.0) 0.69
< 37 weeks 16 (61.5) 4 (50.0)
Birth weight
≥2,500 g 5 (19.2) 2 (25.0) 1.00
< 2,500 g 21 (80.8) 6 (75.0)
Respiratory problems at birth
No 21 (80.8) 6 (75.0) 1.00
Yes 5 (19.2) 2 (25.0)
Ventilatory assistance at birth
No 23 (88.5) 6 (75.0) 0.57
Yes 3 (11.5) 2 (25.0)
Severe bronchiolitis
No 23 (88.5) 8 (100.0) 1.00
Yes 3 (11.5) 0 (0.0)
Rectal temperature ≥38°C
No 21 (80.7) 6 (75.0) 0.98
Yes 5 (19.2) 2 (25.0)
Dyspnea
No 9 (34.6) 4 (50.0) 0.68
Yes 17 (65.4) 4 (50.0)
Wheezes
No 12 (46.1) 5 (62.5) 0.69
Yes 14 (53.9) 3 (37.5)
Rales
No 4 (15.4) 2 (25.0) 1.00
Yes 22 (84.6) 6 (75.0)
Difficulties in feeding
No 13 (50.0) 3 (37.5) 0.69
Yes 13 (50.0) 5 (62.5)
Pneumonia at X-ray
No 8 (30.8) 4 (50.0) 0.41
Yes 18 (69.2) 4 (50.0)
Percentages in parenthesis. P-value for comparison between groups, using chi-square or Fisher’s exact test, as appropriate.
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secretions. Despite it represents the absolute main cause
of bronchiolitis in infants and in various studies it has
been detected as single pathogen in more than 60% of
the cases [1,22], it could be interesting to understand
whether other viruses may cause a similar cardiac invol-
vement as well as sinoatrial blocks could be more severe
and persistent when RSV acts as a co-pathogen with
another virus. On the basis of our data, it can be
hypothesised that RSV infection is one of the possible
causes of these alterations and may even be the direct
cause in some cases.
Our data support the hypothesis that the heart involve-
ment diagnosed in some cases of bronchiolitis associated
with RSV infection [2-8] could be due to direct viral
damage of heart tissue or to immunologic mechanisms
rather than the lung alterations that follow respiratory
infection. In addition to the changes in the heart electrical
conduction system, which was exclusively recorded in our
RSV-positive patients, this hypothesis is supported by the
fact that most of our children had mild or moderate dis-
ease, and were therefore presumably free of pulmonary
hypertension and the significant lung damage conditioning
right heart failure. Furthermore, although the small num-
ber of patients prevented the use of multivariate analysis,
the close correlation between sinoatrial block and RSV
load suggests that RSV could play a direct role in inducing
arrhythmia. This association between high viral load in
respiratory secretions and prevalence of sinoatrial blocks is
intriguing because since the role of viral load in respiratory
secretions is controversial several recent studies have high-
lighted its importance in conditioning respiratory symp-
toms and disease’s severity [31-35].
Conclusions
RSV seems associated with sinoatrial blocks and rhythm
alterations even when the resulting respiratory difficul-
ties are mild or moderate. Further studies are needed to
clarify the mechanisms of these rhythm problems and
whether they remain asymptomatic and transient even
in presence of severe respiratory involvement or chronic
underlying disease. Finally, as RSV can cause respiratory
illnesses other than bronchiolitis, further researches spe-
cifically aimed at defining the relationships between
RSV and the heart are urgently needed regardless of the
clinical picture.
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(PDV): phocine distemper virus; (PCR): polymerase chain reaction; (RSV):
respiratory syncytial virus; (RVID): right ventricular internal dimension in
diastole; (SGOT): serum glutamyl oxaloacetic transaminase; (SGPT): serum
glutamic pyruvic transaminase; (rMSSD): square root of the mean of the
squares of the differences between adjacent NN intervals; (SD): standard
deviation; (SDNN): standard deviation of all NN intervals; (SDANN): standard
deviation of the average of NN intervals in all 5-minute segments of the 24-
h recording.
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